Integrating the care of Metabolic Dysfunction-associated Steatotic Liver Disease into Cardiac Rehabilitation: A Multisystem Approach
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, affecting 1 in 3 adults and driven by the rising incidence of obesity and type 2 diabetes. MASLD is also a significant contributor to cardio... ...
